Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Cash from Investing Activities (2012 - 2026)

Precigen (PGEN) posted quarterly Cash from Investing Activities of $21.0 million for Q1 2026, up 424.72% year-over-year from $4.0 million in Q1 2025, and down 47.41% quarter-over-quarter from $39.9 million in Q4 2025.

Analysis

Precigen (PGEN) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Cash from Investing Activities for 15 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 424.72% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $25.9 million (up 150.55% YoY), while the FY2025 annual figure was -$1.5 million, up 92.59% from the prior year.
  • Cash from Investing Activities retreated to $21.0 million in Q1 2026 per PGEN's latest filing, from $39.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $181.9 million in Q3 2022 and bottomed at -$65.4 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged $13.1 million across 5 years, with a median of $15.0 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 726.13% — and 2025, when it slumped 1221.28%.
  • Precigen's Cash from Investing Activities stood at $11.4 million in 2022, then climbed by 16.39% to $13.3 million in 2023, then plunged by 591.74% to -$65.4 million in 2024, then surged by 160.99% to $39.9 million in 2025, then slumped by 47.41% to $21.0 million in 2026.
  • Business Quant data shows PGEN's Cash from Investing Activities at $21.0 million in Q1 2026, $39.9 million in Q4 2025, and -$63.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 26.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.69 Mn
Mar 31, 2026 20.97 Mn
Dec 31, 2025 39.87 Mn
Sep 30, 2025 -63.39 Mn
Jun 30, 2025 28.44 Mn
Mar 31, 2025 -6.46 Mn
Dec 31, 2024 -65.37 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 14.96 Mn
Mar 31, 2024 24.05 Mn
Dec 31, 2023 13.29 Mn
Sep 30, 2023 10.53 Mn
Jun 30, 2023 23.50 Mn
Mar 31, 2023 -50.41 Mn
Dec 31, 2022 11.42 Mn
Sep 30, 2022 181.86 Mn
Jun 30, 2022 16.57 Mn
Mar 31, 2022 16.57 Mn
Dec 31, 2021 15.93 Mn
Sep 30, 2021 22.01 Mn